Aspect Imaging (www.aspectimaging.com) is the world’s leader in high-performance compact benchtop MRI imaging systems for preclinical, clinical and advanced industrial applications. In preclinical research, Aspect’s M2™ platform and suite of products enables academic researchers and pharmaceutical companies to harness the power and insights of MRI but without the cost, complexity and technical burden of traditional MRI systems. With Aspect’s integrated and simple-to-use platform, researchers can derive deep insights into their biological questions quickly, easily and cost-effectively - - and all with the push of a button. Because the system that has no fringe magnetic field, the M2 can be placed anywhere in a working lab including at a scientist’s benchtop. The M2™ platform is used by leading institutions for a broad range of in vivo, ex vivo and in vitro applicationsincluding high-resolution 3D anatomical, molecular, functional and multi-modality imaging. The Aspect high-performance MRI system is used to quantify the expression of disease, to monitor disease progression and to assess therapeutic efficacy and response.
The Company’s breakthrough technology and related IP - - compact high-performance permanent magnets - - addresses the primary obstacles that exist in the current MRI market. These include the high cost of purchasing, operating and maintaining high-field MRI systems, the complexity of operating complex research-based MRI systems, and the physical limitations placed on traditional MRI systems due to their active magnetic fields. The Aspect’s M2 system solves all these issues as it is affordable to purchase, its virtually maintenance-free, it has no active magnetic field so it can be placed anywhere in a research lab and it has been designed to be operated by a researchers with no prior imaging or MRI experience. Because of this simplicity of operation, the power of MRI as a diagnostic standard is now available to be applied to complex biological questions in many research application areas including cancer research, neurobiology, obesity and diabetes, in vivo and ex vivo (ie. 3D histology) anatomical imaging. The system can leverage a variety of techniques including 2D, 3D and contrast agent acquisition and analysis in addition to participating easily in multi-modality applications and image co-registration.
The Company’s vision is to be the leading choice of compact high-performance desktop MRI systems by leading academic and drug development researchers, clinicians, and industrial scientists worldwide and to continue to commercialize innovative and dependable products and solutions to help resolve our customer’s complex needs.
Aspect has a of seasoned Management team of global executives with a proven history in the successful development and commercialization of MRI, imaging and medical devices and in developing global organizations that drive significant shareholder value. Aspect, the leading high-performance desktop MRI company globally, has its headquarters, research and development and manufacturing based in Shoam, Israel with worldwide commercial operations based in Toronto, Canada.